Pubblicazioni

  1. Kuwana, M, Allanore, Y, Denton, CP, Distler, JH, Steen, V, Khanna, D et al.. Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: subgroup analyses by autoantibody status and skin score. Arthritis Rheumatol. 2021; :. doi: 10.1002/art.41965. PubMed PMID:34514739 .
  2. Ferri, C, Giuggioli, D, Raimondo, V, L'Andolina, M, Dagna, L, Tavoni, A et al.. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. Curr Pharm Des. 2021; :. doi: 10.2174/1381612827666210903103935. PubMed PMID:34477509 .
  3. Wang, Y, Xie, X, Zhang, C, Su, M, Gao, S, Wang, J et al.. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis. 2021; :. doi: 10.1136/annrheumdis-2021-220066. PubMed PMID:34462261 .
  4. Wang, Y, Chen, S, Zheng, S, Lin, J, Hu, S, Zhuang, J et al.. The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases. Arthritis Res Ther. 2021;23 (1):212. doi: 10.1186/s13075-021-02586-9. PubMed PMID:34391465 PubMed Central PMC8364073.
  5. Spiera, R, Khanna, D, Kuwana, M, Furst, DE, Frech, TM, Hummers, L et al.. A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale. Clin Exp Rheumatol. ;39 Suppl 131 (4):124-133. . PubMed PMID:34323681 .
  6. Orlandi, M, Landini, N, Sambataro, G, Nardi, C, Tofani, L, Bruni, C et al.. THE ROLE OF CHEST CT IN DECIPHERING INTERSTITIAL LUNG INVOLVEMENT: SYSTEMIC SCLEROSIS VERSUS COVID-19. Rheumatology (Oxford). 2021; :. doi: 10.1093/rheumatology/keab615. PubMed PMID:34320649 .
  7. Karalilova, RV, Batalov, ZA, Sapundzhieva, TL, Matucci-Cerinic, M, Batalov, AZ. Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound. Rheumatol Int. 2021;41 (10):1743-1753. doi: 10.1007/s00296-021-04956-7. PubMed PMID:34313812 PubMed Central PMC8390399.
  8. Mahran, SA, Galluccio, F, Khedr, TM, Elsonbaty, A, Allam, AE, Garcia Martos, A et al.. Peripheral neuropathy in systemic lupus erythematosus: what can neuromuscular ultrasonography (NMUS) tell us? A cross-sectional study. Lupus Sci Med. 2021;8 (1):. doi: 10.1136/lupus-2021-000521. PubMed PMID:34312211 PubMed Central PMC8314698.
  9. Atzori, L, Ferreli, C, Matucci-Cerinic, C, Pilloni, L, Rongioletti, F. Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition. Dermatopathology (Basel). 2021;8 (3):229-235. doi: 10.3390/dermatopathology8030028. PubMed PMID:34287266 PubMed Central PMC8293241.
  10. Matucci-Cerinic, M, Hughes, M, Taliani, G, Kahaleh, B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev. 2021;20 (10):102899. doi: 10.1016/j.autrev.2021.102899. PubMed PMID:34274540 PubMed Central PMC8280663.
  11. Campochiaro, C, De Luca, G, Farina, N, Vignale, D, Palmisano, A, Matucci-Cerinic, M et al.. Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis. Scand J Rheumatol. 2021; :1-3. doi: 10.1080/03009742.2021.1932582. PubMed PMID:34232807 .
  12. Bellando-Randone, S, Russo, E, Venerito, V, Matucci-Cerinic, M, Iannone, F, Tangaro, S et al.. Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach. J Pers Med. 2021;11 (7):. doi: 10.3390/jpm11070625. PubMed PMID:34209167 PubMed Central PMC8306274.
  13. Melchiorre, D, Ceccherini, MT, Romano, E, Cometi, L, El-Aoufy, K, Bellando-Randone, S et al.. Oral Lactobacillus Species in Systemic Sclerosis. Microorganisms. 2021;9 (6):. doi: 10.3390/microorganisms9061298. PubMed PMID:34203626 PubMed Central PMC8232208.
  14. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy. Life (Basel). 2021;11 (7):. doi: 10.3390/life11070610. PubMed PMID:34202703 PubMed Central PMC8307837.
  15. Matucci-Cerinic, C, Caorsi, R, Consolaro, A, Rosina, S, Civino, A, Ravelli, A et al.. Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?. Front Pediatr. 2021;9 :680813. doi: 10.3389/fped.2021.680813. PubMed PMID:34178896 PubMed Central PMC8220809.
  16. Maddali Bongi, S, Passalacqua, M, Landi, G, Mikhaylova, S, Tofani, L, Del Rosso, A et al.. Rehabilitation of the face and temporomandibular joint in systemic sclerosis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211020171. doi: 10.1177/1759720X211020171. PubMed PMID:34163540 PubMed Central PMC8191075.
  17. Hughes, M, Heal, C, Henes, J, Balbir-Gurman, A, Distler, JHW, Airò, P et al.. Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology (Oxford). 2021; :. doi: 10.1093/rheumatology/keab510. PubMed PMID:34146098 .
  18. Hughes, M, Allanore, Y, El Aoufy, K, Denton, CP, Khanna, D, Krieg, T et al.. A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative Review. JAMA Dermatol. 2021;157 (7):851-858. doi: 10.1001/jamadermatol.2021.1463. PubMed PMID:34037677 .
  19. Tesei, G, Cometi, L, Nacci, F, Terenzi, R, Tofani, L, Capassoni, M et al.. Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211014019. doi: 10.1177/1759720X211014019. PubMed PMID:34025783 PubMed Central PMC8120535.
  20. De Luca, G, Tomelleri, A, Dagna, L, Matucci-Cerinic, M. The target on B cells in Systemic Sclerosis: a "midsummer dream" to extinguish inflammation and prevent early disease progression to fibrosis. Clin Rheumatol. 2021;40 (7):2529-2533. doi: 10.1007/s10067-021-05733-4. PubMed PMID:34021841 .
  21. Matucci-Cerinic, C, Viglizzo, G, Ravelli, A, Occella, C. Neonatal lupus erythematosus in dizygotic twins with anti-RNP antibodies. Clin Exp Rheumatol. 2021; :. . PubMed PMID:34001302 .
  22. Nevskaya, T, Pope, JE, Turk, MA, Shu, J, Marquardt, A, van den Hoogen, F et al.. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets. J Rheumatol. 2021; :. doi: 10.3899/jrheum.201594. PubMed PMID:33993109 .
  23. Galluccio, F, D'Angela, D, Polistena, B, Porta, F, Barskova, T, Tofani, L et al.. Comparison of three treatment protocols with intra-articular low or intermediate molecular weight hyaluronic acid in early symptomatic knee osteoarthritis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X21994024. doi: 10.1177/1759720X21994024. PubMed PMID:33959197 PubMed Central PMC8064515.
  24. Russo, B, Ben Shimol, J, Matucci-Cerinic, M, Bruni, C. Systemic sclerosis and COVID-19: what's new in the literature. Clin Exp Rheumatol. ;39 Suppl 131 (4):157-158. . PubMed PMID:33938792 .
  25. Mendonça, LO, Matucci-Cerinic, C, Terranova, P, Casabona, F, Bovis, F, Caorsi, R et al.. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders. Rheumatology (Oxford). 2021; :. doi: 10.1093/rheumatology/keab361. PubMed PMID:33909886 .
  26. Lescoat, A, Varga, J, Matucci-Cerinic, M, Khanna, D. New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. Expert Opin Investig Drugs. 2021;30 (6):635-652. doi: 10.1080/13543784.2021.1923693. PubMed PMID:33909517 PubMed Central PMC8292968.
  27. De Luca, G, Cavalli, G, Campochiaro, C, Bruni, C, Tomelleri, A, Dagna, L et al.. Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement. Front Immunol. 2021;12 :653950. doi: 10.3389/fimmu.2021.653950. PubMed PMID:33833766 PubMed Central PMC8021854.
  28. d'Alessandro, M, Bellisai, F, Bergantini, L, Cameli, P, D'Alessandro, R, Mazzei, MA et al.. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis. Eur J Clin Invest. 2021;51 (8):e13543. doi: 10.1111/eci.13543. PubMed PMID:33759179 .
  29. Hughes, M, Allanore, Y, Chung, L, Pauling, JD, Denton, CP, Matucci-Cerinic, M et al.. Author Correction: Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol. 2021;17 (4):246. doi: 10.1038/s41584-021-00591-5. PubMed PMID:33750917 .
  30. Baimukhamedov, C, Barskova, T, Matucci-Cerinic, M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3 (5):e324-e325. doi: 10.1016/S2665-9913(21)00067-9. PubMed PMID:33748780 PubMed Central PMC7963449.
  31. Hughes, M, Kahaleh, B, Denton, CP, Mason, JC, Matucci-Cerinic, M. ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology (Oxford). 2021; :. doi: 10.1093/rheumatology/keab278. PubMed PMID:33744916 .
  32. Lazzeri, C, Bonizzoli, M, Batacchi, S, Socci, F, Matucci-Cerinic, M, Peris, A et al.. Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome. Intern Emerg Med. 2021; :. doi: 10.1007/s11739-021-02646-7. PubMed PMID:33704675 PubMed Central PMC7947148.
  33. Giuggioli, D, Bruni, C, Cacciapaglia, F, Dardi, F, De Cata, A, Del Papa, N et al.. Pulmonary arterial hypertension: guidelines and unmet clinical needs. Reumatismo. 2021;72 (4):228-246. doi: 10.4081/reumatismo.2020.1310. PubMed PMID:33677950 .
  34. Suliman, YA, Bruni, C, Hughes, M, Matucci-Cerinic, M, Furst, DE. Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation steps. Semin Arthritis Rheum. 2021;51 (2):425-429. doi: 10.1016/j.semarthrit.2021.02.008. PubMed PMID:33677309 .
  35. Ruaro, B, Confalonieri, M, Matucci-Cerinic, M, Salton, F, Confalonieri, P, Santagiuliana, M et al.. The Treatment of Lung Involvement in Systemic Sclerosis. Pharmaceuticals (Basel). 2021;14 (2):. doi: 10.3390/ph14020154. PubMed PMID:33668530 PubMed Central PMC7918752.
  36. Cappelli, F, Zampieri, M, Fumagalli, C, Nardi, G, Del Monaco, G, Matucci Cerinic, M et al.. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. J Intern Med. 2021;289 (6):831-839. doi: 10.1111/joim.13200. PubMed PMID:33615623 .
  37. Cox, M, Sandler, RD, Matucci-Cerinic, M, Hughes, M. Bone health in idiopathic inflammatory myopathies. Autoimmun Rev. 2021;20 (4):102782. doi: 10.1016/j.autrev.2021.102782. PubMed PMID:33609795 .
  38. Coi, A, Barsotti, S, Santoro, M, Almerigogna, F, Bargagli, E, Caproni, M et al.. Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy). Orphanet J Rare Dis. 2021;16 (1):90. doi: 10.1186/s13023-021-01733-4. PubMed PMID:33596949 PubMed Central PMC7890847.
  39. Rosa, I, Romano, E, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis. World J Stem Cells. 2021;13 (1):30-48. doi: 10.4252/wjsc.v13.i1.30. PubMed PMID:33584978 PubMed Central PMC7859990.
  40. Bruni, C, Cometi, L, Gigante, A, Rosato, E, Matucci-Cerinic, M. Prediction and primary prevention of major vascular complications in systemic sclerosis. Eur J Intern Med. 2021;87 :51-58. doi: 10.1016/j.ejim.2021.01.022. PubMed PMID:33551291 .
  41. Hughes, M, Bruni, C, Ruaro, B, Confalonieri, M, Matucci-Cerinic, M, Bellando-Randone, S et al.. Digital Ulcers in Systemic Sclerosis. Presse Med. 2021;50 (1):104064. doi: 10.1016/j.lpm.2021.104064. PubMed PMID:33548375 .
  42. Ferri, C, Giuggioli, D, Raimondo, V, Dagna, L, Riccieri, V, Zanatta, E et al.. COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study. Lancet Rheumatol. 2021;3 (3):e166-e168. doi: 10.1016/S2665-9913(21)00007-2. PubMed PMID:33521657 PubMed Central PMC7836813.
  43. Landini, N, Orlandi, M, Fusaro, M, Ciet, P, Nardi, C, Bertolo, S et al.. The Role of Imaging in COVID-19 Pneumonia Diagnosis and Management: Main Positions of the Experts, Key Imaging Features and Open Answers. J Cardiovasc Echogr. 2020;30 (Suppl 2):S25-S30. doi: 10.4103/jcecho.jcecho_59_20. PubMed PMID:33489733 PubMed Central PMC7811702.
  44. Andreucci, E, Margheri, F, Peppicelli, S, Bianchini, F, Ruzzolini, J, Laurenzana, A et al.. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology (Oxford). 2021; :. doi: 10.1093/rheumatology/keab022. PubMed PMID:33471123 .
  45. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Antunes, AM, Arnaud, L et al.. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021;17 (3):177-184. doi: 10.1038/s41584-020-00565-z. PubMed PMID:33408338 PubMed Central PMC7786339.
  46. Bruni, C, Matucci-Cerinic, M. Response to: 'Correspondence on 'Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management'' by Snarskaya and Vasileva. Ann Rheum Dis. 2021; :. doi: 10.1136/annrheumdis-2020-219533. PubMed PMID:33408075 .
  47. Rosa, I, Faussone-Pellegrini, MS, Romano, E, Ibba-Manneschi, L, Matucci-Cerinic, M, Manetti, M et al.. Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium. J Cell Mol Med. 2021;25 (4):2274-2278. doi: 10.1111/jcmm.16225. PubMed PMID:33350073 PubMed Central PMC7882959.
  48. Orlandi, M, Landini, N, Bruni, C, Sambataro, G, Nardi, C, Bargagli, E et al.. Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review. Rheumatology (Oxford). 2020;59 (12):3645-3656. doi: 10.1093/rheumatology/keaa451. PubMed PMID:33313932 .
  49. Orlandi, M, Landini, N, Bruni, C, Colagrande, S, Matucci-Cerinic, M, Kuwana, M et al.. Infection or Autoimmunity? The Clinical Challenge of Interstitial Lung Disease in Systemic Sclerosis During the COVID-19 Pandemic. J Rheumatol. 2021;48 (5):790-792. doi: 10.3899/jrheum.200832. PubMed PMID:33262297 .
  50. Johnson, SR, van den Hoogen, F, Devakandan, K, Matucci-Cerinic, M, Pope, JE. Systemic sclerosis: To subset or not to subset, that is the question. Eur J Rheumatol. 2020;7 (Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. PubMed PMID:33164736 PubMed Central PMC7647684.
  51. Del Galdo, F, Matucci-Cerinic, M. A special European Journal of Rheumatology issue on systemic sclerosis: What and why?. Eur J Rheumatol. 2020;7 (Suppl 3):S137-S138. doi: 10.5152/eurjrheum.2020.090121. PubMed PMID:33164730 PubMed Central PMC7647686.
  52. Gargani, L, Bruni, C, De Marchi, D, Romei, C, Guiducci, S, Bellando-Randone, S et al.. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression. Clin Rheumatol. 2021;40 (5):1903-1912. doi: 10.1007/s10067-020-05491-9. PubMed PMID:33161470 .
  53. Bruni, C, Gentileschi, S, Pacini, G, Baldi, C, Capassoni, M, Tofani, L et al.. The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases. Ther Adv Musculoskelet Dis. 2020;12 :1759720X20964031. doi: 10.1177/1759720X20964031. PubMed PMID:33133246 PubMed Central PMC7576915.
  54. Benvenuti, F, Zanatta, E, Avouac, J, Müller-Ladner, U, Cozzi, F, Hoffmann-Vold, AM et al.. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Rev Clin Immunol. 2020;16 (11):1065-1074. doi: 10.1080/1744666X.2021.1836962. PubMed PMID:33076716 .
  55. Maraghelli, D, Brandi, ML, Matucci Cerinic, M, Peired, AJ, Colagrande, S. Edema-like marrow signal intensity: a narrative review with a pictorial essay. Skeletal Radiol. 2021;50 (4):645-663. doi: 10.1007/s00256-020-03632-4. PubMed PMID:33029648 PubMed Central PMC7875957.
  56. Khanna, D, Lin, CJF, Furst, DE, Goldin, J, Kim, G, Kuwana, M et al.. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2020;8 (10):963-974. doi: 10.1016/S2213-2600(20)30318-0. PubMed PMID:32866440 .
  57. Bruni, C, Tashkin, DP, Steen, V, Allanore, Y, Distler, O, Grotts, J et al.. Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials. Clin Exp Rheumatol. ;38 Suppl 125 (3):161-168. . PubMed PMID:32865169 .
  58. Romano, E, Rosa, I, Fioretto, BS, Lucattelli, E, Innocenti, M, Ibba-Manneschi, L et al.. A Two-Step Immunomagnetic Microbead-Based Method for the Isolation of Human Primary Skin Telocytes/CD34+ Stromal Cells. Int J Mol Sci. 2020;21 (16):. doi: 10.3390/ijms21165877. PubMed PMID:32824287 PubMed Central PMC7461544.
  59. Vannucchi, AM, Sordi, B, Morettini, A, Nozzoli, C, Poggesi, L, Pieralli, F et al.. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021;35 (4):1121-1133. doi: 10.1038/s41375-020-01018-y. PubMed PMID:32814839 PubMed Central PMC7437386.
  60. Wang, Y, Du, G, Zhang, G, Matucci-Cerinic, M, Furst, DE. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future. Ann Rheum Dis. 2020; :. doi: 10.1136/annrheumdis-2020-218594. PubMed PMID:32759260 .
  61. Burmester, GR, Buttgereit, F, Bernasconi, C, Álvaro-Gracia, JM, Castro, N, Dougados, M et al.. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Lancet. 2020;396 (10246):267-276. doi: 10.1016/S0140-6736(20)30636-X. PubMed PMID:32711802 .
  62. Avanoǧlu Güler, A, Rossi, FW, Bellando-Randone, S, Prevete, N, Tufan, A, Manetti, M et al.. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis. Front Immunol. 2020;11 :1249. doi: 10.3389/fimmu.2020.01249. PubMed PMID:32636845 PubMed Central PMC7318896.
  63. Occhipinti, M, Bruni, C, Camiciottoli, G, Bartolucci, M, Bellando-Randone, S, Bassetto, A et al.. Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT. Ann Rheum Dis. 2020;79 (9):1210-1217. doi: 10.1136/annrheumdis-2020-217359. PubMed PMID:32606043 .
  64. Bruni, C, De Luca, G, Lazzaroni, MG, Zanatta, E, Lepri, G, Airò, P et al.. Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review. Eur J Intern Med. 2020;78 :17-25. doi: 10.1016/j.ejim.2020.05.042. PubMed PMID:32540411 .
  65. Fioretto, BS, Rosa, I, Romano, E, Wang, Y, Guiducci, S, Zhang, G et al.. The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Ther Adv Musculoskelet Dis. 2020;12 :1759720X20918456. doi: 10.1177/1759720X20918456. PubMed PMID:32523636 PubMed Central PMC7236401.
  66. Bruni, C, Bitti, R, Nacci, F, Cometi, L, Tofani, L, Bartoli, F et al.. Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases. Clin Rheumatol. 2021;40 (1):85-91. doi: 10.1007/s10067-020-05199-w. PubMed PMID:32514676 .
  67. Orlandi, M, Lepri, G, Bruni, C, Wang, Y, Bartoloni, A, Zammarchi, L et al.. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol. 2020;39 (7):2043-2047. doi: 10.1007/s10067-020-05193-2. PubMed PMID:32514674 PubMed Central PMC7276334.
  68. Varjú, C, Kumánovics, G, Czirják, L, Matucci-Cerinic, M, Minier, T. Sclerodermalike syndromes: Great imitators. Clin Dermatol. ;38 (2):235-249. doi: 10.1016/j.clindermatol.2019.10.010. PubMed PMID:32513403 .
  69. Avouac, J, Airó, P, Carlier, N, Matucci-Cerinic, M, Allanore, Y. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020; :. doi: 10.1136/annrheumdis-2020-217864. PubMed PMID:32503849 .
  70. Hughes, M, Rogers, S, Lepri, G, Bruni, C, Matucci-Cerinic, M. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection. Br J Dermatol. 2020;183 (3):596-598. doi: 10.1111/bjd.19243. PubMed PMID:32460349 PubMed Central PMC7283762.
  71. Campochiaro, C, De Luca, G, Lazzaroni, MG, Zanatta, E, Bosello, SL, De Santis, M et al.. Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study. Rheumatology (Oxford). 2020;59 (12):3731-3736. doi: 10.1093/rheumatology/keaa136. PubMed PMID:32413118 .
  72. Lepri, G, Orlandi, M, Lazzeri, C, Bruni, C, Hughes, M, Bonizzoli, M et al.. The emerging role of lung ultrasound in COVID-19 pneumonia. Eur J Rheumatol. 2020;7 (Suppl 2):S129-S133. doi: 10.5152/eurjrheum.2020.2063. PubMed PMID:32392461 PubMed Central PMC7431334.
  73. Lagi, F, Piccica, M, Graziani, L, Vellere, I, Botta, A, Tilli, M et al.. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020;25 (17):. doi: 10.2807/1560-7917.ES.2020.25.17.2000556. PubMed PMID:32372754 PubMed Central PMC7201949.
  74. Cometi, L, Bruni, C, Chiti, N, Tofani, L, Nacci, F, Bartoli, F et al.. Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases. J Clin Med. 2020;9 (5):. doi: 10.3390/jcm9051310. PubMed PMID:32370139 PubMed Central PMC7290363.
  75. Gargani, L, Bruni, C, Romei, C, Frumento, P, Moreo, A, Agoston, G et al.. Prognostic Value of Lung Ultrasound B-Lines in Systemic Sclerosis. Chest. 2020;158 (4):1515-1525. doi: 10.1016/j.chest.2020.03.075. PubMed PMID:32360727 .
  76. Matucci-Cerinic, M, Bruni, C, Allanore, Y, Clementi, M, Dagna, L, Damjanov, NS et al.. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Ann Rheum Dis. 2020;79 (6):724-726. doi: 10.1136/annrheumdis-2020-217407. PubMed PMID:32349982 .
  77. Ferri, C, Giuggioli, D, Guiducci, S, Lumetti, F, Bajocchi, G, Magnani, L et al.. Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum. Clin Exp Rheumatol. ;38 Suppl 125 (3):40-47. . PubMed PMID:32301427 .
  78. Khanna, D, Allanore, Y, Denton, CP, Kuwana, M, Matucci-Cerinic, M, Pope, JE et al.. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. Ann Rheum Dis. 2020;79 (5):618-625. doi: 10.1136/annrheumdis-2019-216823. PubMed PMID:32299845 PubMed Central PMC7213318.
  79. Tufan, A, Avanoğlu Güler, A, Matucci-Cerinic, M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50 (SI-1):620-632. doi: 10.3906/sag-2004-168. PubMed PMID:32299202 PubMed Central PMC7195984.
  80. Gigante, A, Bruni, C, Lepri, G, Tesei, G, Maestripieri, V, Guiducci, S et al.. The Renal Resistive Index: A New Biomarker for the Follow-up of Vascular Modifications in Systemic Sclerosis. J Rheumatol. 2021;48 (2):241-246. doi: 10.3899/jrheum.191101. PubMed PMID:32238514 .
  81. Hughes, M, Heal, C, Siegert, E, Hachulla, E, Airó, P, Riccardi, A et al.. Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2020;79 (8):1123-1125. doi: 10.1136/annrheumdis-2020-217035. PubMed PMID:32213494 .
  82. Blaja, E, Jordan, S, Mihai, CM, Dobrota, R, Becker, MO, Maurer, B et al.. The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease?. J Rheumatol. 2021;48 (1):82-86. doi: 10.3899/jrheum.190976. PubMed PMID:32173655 .
  83. Castellví, I, Elhai, M, Bruni, C, Airò, P, Jordan, S, Beretta, L et al.. Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience. Semin Arthritis Rheum. 2020;50 (6):1489-1493. doi: 10.1016/j.semarthrit.2019.12.004. PubMed PMID:32165035 .
  84. Bellando-Randone, S, Matucci-Cerinic, M. The race against time to disclose lung inflammation in interstitial lung disease in systemic sclerosis: is PET scan the winning solution?. Rheumatology (Oxford). 2020;59 (6):1198-1199. doi: 10.1093/rheumatology/keaa077. PubMed PMID:32159796 PubMed Central PMC7850146.
  85. Nagaraja, V, Matucci-Cerinic, M, Furst, DE, Kuwana, M, Allanore, Y, Denton, CP et al.. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. Arthritis Rheumatol. 2020;72 (7):1049-1058. doi: 10.1002/art.41246. PubMed PMID:32134199 PubMed Central PMC7329619.
  86. Hughes, M, Allanore, Y, Chung, L, Pauling, JD, Denton, CP, Matucci-Cerinic, M et al.. Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol. 2020;16 (4):208-221. doi: 10.1038/s41584-020-0386-4. PubMed PMID:32099191 .
  87. Hughes, M, Pauling, JD, Jones, J, Denton, CP, Domsic, RT, Frech, TM et al.. Patient experiences of digital ulcer development and evolution in systemic sclerosis. Rheumatology (Oxford). 2020;59 (8):2156-2158. doi: 10.1093/rheumatology/keaa037. PubMed PMID:32031630 .
  88. Hughes, M, Alcacer-Pitarch, B, Gheorghiu, AM, Praino, E, Sandler, RD, Tavor, Y et al.. Digital ulcer debridement in systemic sclerosis: a systematic literature review. Clin Rheumatol. 2020;39 (3):805-811. doi: 10.1007/s10067-019-04924-4. PubMed PMID:31955323 .
  89. Quartuccio, L, Bond, M, Isola, M, Monti, S, Felicetti, M, Furini, F et al.. Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors. J Autoimmun. 2020;108 :102397. doi: 10.1016/j.jaut.2019.102397. PubMed PMID:31926833 .
  90. Wang, Y, Chen, S, Chen, J, Xie, X, Gao, S, Zhang, C et al.. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity. Ann Rheum Dis. 2020;79 (2):268-275. doi: 10.1136/annrheumdis-2019-215533. PubMed PMID:31848144 .
  91. Sambataro, G, Ferro, F, Orlandi, M, Sambataro, D, Torrisi, SE, Quartuccio, L et al.. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology. Autoimmun Rev. 2020;19 (2):102447. doi: 10.1016/j.autrev.2019.102447. PubMed PMID:31843713 .
  92. Hughes, M, Pauling, JD, Jones, J, Denton, CP, Domsic, RT, Frech, TM et al.. Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2020;72 (5):723-733. doi: 10.1002/acr.24127. PubMed PMID:31841265 .
  93. Frantz, C, Huscher, D, Avouac, J, Hachulla, E, Balbir-Gurman, A, Riemekasten, G et al.. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database. Autoimmun Rev. 2020;19 (2):102452. doi: 10.1016/j.autrev.2019.102452. PubMed PMID:31838157 .
  94. Manetti, M, Romano, E, Rosa, I, Fioretto, BS, Guiducci, S, Bellando-Randone, S et al.. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence. Int J Mol Sci. 2019;20 (24):. doi: 10.3390/ijms20246189. PubMed PMID:31817940 PubMed Central PMC6940874.
  95. Sandler, RD, Matucci-Cerinic, M, Hughes, M. Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum. 2020;50 (2):329-334. doi: 10.1016/j.semarthrit.2019.11.003. PubMed PMID:31812353 .
  96. Bellando-Randone, S, Matucci-Cerinic, M. Very early systemic sclerosis. Best Pract Res Clin Rheumatol. 2019;33 (4):101428. doi: 10.1016/j.berh.2019.101428. PubMed PMID:31810547 .
  97. Wang, Y, Chen, S, Lin, J, Xie, X, Hu, S, Lin, Q et al.. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease. Rheumatology (Oxford). 2020;59 (8):2024-2029. doi: 10.1093/rheumatology/kez571. PubMed PMID:31794028 PubMed Central PMC7382590.
  98. Mihai, C, Distler, O, Gheorghiu, AM, Constantin, PI, Dobrota, R, Jordan, S et al.. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort. Rheumatology (Oxford). 2020;59 (8):2016-2023. doi: 10.1093/rheumatology/kez558. PubMed PMID:31790136 .
  99. Mavrogeni, S, Gargani, L, Pepe, A, Monti, L, Markousis-Mavrogenis, G, De Santis, M et al.. Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS). Rheumatology (Oxford). 2020;59 (8):1938-1948. doi: 10.1093/rheumatology/kez494. PubMed PMID:31764972 PubMed Central PMC7382593.
  100. Cavagna, L, Trallero-Araguás, E, Meloni, F, Cavazzana, I, Rojas-Serrano, J, Feist, E et al.. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. J Clin Med. 2019;8 (11):. doi: 10.3390/jcm8112013. PubMed PMID:31752231 PubMed Central PMC6912490.
  101. Favalli, EG, Matucci-Cerinic, M, Szekanecz, Z. The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis. Autoimmun Rev. 2020;19 (1):102421. doi: 10.1016/j.autrev.2019.102421. PubMed PMID:31733368 .
  102. Jaeger, VK, Tikly, M, Xu, D, Siegert, E, Hachulla, E, Airò, P et al.. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study. Rheumatology (Oxford). 2020;59 (7):1684-1694. doi: 10.1093/rheumatology/kez486. PubMed PMID:31680161 .
  103. Naredo, E, Pascau, J, Damjanov, N, Lepri, G, Gordaliza, PM, Janta, I et al.. Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: a preliminary report. Rheumatology (Oxford). 2020;59 (7):1671-1678. doi: 10.1093/rheumatology/kez439. PubMed PMID:31665474 .
  104. Blagojevic, J, Legendre, P, Matucci-Cerinic, M, Mouthon, L. Is there today a place for corticosteroids in the treatment of scleroderma?. Autoimmun Rev. 2019;18 (12):102403. doi: 10.1016/j.autrev.2019.102403. PubMed PMID:31639515 .
  105. Matei, AE, Distler, JHW. Response to: 'In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?' by Manetti and Matucci-Cerinic. Ann Rheum Dis. 2021;80 (9):e150. doi: 10.1136/annrheumdis-2019-216393. PubMed PMID:31615754 .
  106. Manetti, M, Matucci-Cerinic, M. In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?. Ann Rheum Dis. 2021;80 (9):e149. doi: 10.1136/annrheumdis-2019-216371. PubMed PMID:31582376 .
  107. Bruni, C, Rosato, E, Maestripieri, V, Gigante, A, Tesei, G, Bellando-Randone, S et al.. The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs. Eur J Intern Med. 2019;70 :43-49. doi: 10.1016/j.ejim.2019.09.001. PubMed PMID:31540806 .
  108. Blagojevic, J, AlOdhaibi, KA, Aly, AM, Bellando-Randone, S, Lepri, G, Bruni, C et al.. Pregnancy in Systemic Sclerosis: Results of a Systematic Review and Metaanalysis. J Rheumatol. 2020;47 (6):881-887. doi: 10.3899/jrheum.181460. PubMed PMID:31474594 .
  109. Manetti, M, Romano, E, Rosa, I, Fioretto, BS, Praino, E, Guiducci, S et al.. Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications. J Clin Med. 2019;8 (8):. doi: 10.3390/jcm8081256. PubMed PMID:31430950 PubMed Central PMC6723717.
  110. Terenzi, R, Karalilova, R, Lepri, G, Bruni, C, Bellando-Randone, S, Manetti, M et al.. Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study. Rheumatology (Oxford). 2020;59 (3):580-585. doi: 10.1093/rheumatology/kez322. PubMed PMID:31410485 .
  111. Valentini, G, Huscher, D, Riccardi, A, Fasano, S, Irace, R, Messiniti, V et al.. Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study. Ann Rheum Dis. 2019;78 (11):1576-1582. doi: 10.1136/annrheumdis-2019-215486. PubMed PMID:31391176 .
  112. Khanna, D, Spino, C, Johnson, S, Chung, L, Whitfield, ML, Denton, CP et al.. Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis Rheumatol. 2020;72 (1):125-136. doi: 10.1002/art.41055. PubMed PMID:31342624 PubMed Central PMC6935399.
  113. Manetti, M, Linari, S, Romano, E, Rosa, I, Carulli, C, Innocenti, M et al.. TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A. J Clin Med. 2019;8 (7):. doi: 10.3390/jcm8070939. PubMed PMID:31261789 PubMed Central PMC6678637.
  114. Becker, M, Graf, N, Sauter, R, Allanore, Y, Curram, J, Denton, CP et al.. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Ann Rheum Dis. 2019;78 (9):1242-1248. doi: 10.1136/annrheumdis-2019-215145. PubMed PMID:31227488 PubMed Central PMC6788922.
  115. Jaworski, J, Matucci-Cerinic, M, Schulze-Koops, H, Buch, MH, Kucharz, EJ, Allanore, Y et al.. Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study. Arthritis Res Ther. 2019;21 (1):130. doi: 10.1186/s13075-019-1907-x. PubMed PMID:31138316 PubMed Central PMC6540397.
  116. Mor, A, Segal Salto, M, Katav, A, Barashi, N, Edelshtein, V, Manetti, M et al.. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis. Ann Rheum Dis. 2019;78 (9):1260-1268. doi: 10.1136/annrheumdis-2019-215119. PubMed PMID:31129606 PubMed Central PMC6788878.
  117. Blagojevic, J, Abignano, G, Avouac, J, Cometi, L, Frerix, M, Bellando-Randone, S et al.. Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study. Clin Rheumatol. 2020;39 (1):27-36. doi: 10.1007/s10067-019-04564-8. PubMed PMID:31111363 .
  118. de Vries-Bouwstra, JK, Allanore, Y, Matucci-Cerinic, M, Balbir-Gurman, A. Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis. J Rheumatol. 2020;47 (2):249-254. doi: 10.3899/jrheum.181173. PubMed PMID:31043545 .
  119. Romano, E, Rosa, I, Fioretto, BS, Guiducci, S, Manetti, M, Matucci-Cerinic, M et al.. A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems. Clin Exp Rheumatol. ;37 Suppl 119 (4):133-140. . PubMed PMID:31025932 .
  120. Negrini, S, Magnani, O, Matucci-Cerinic, M, Carignola, R, Data, V, Montabone, E et al.. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study. Clin Exp Med. 2019;19 (3):357-366. doi: 10.1007/s10238-019-00553-y. PubMed PMID:30989453 .
  121. Sobanski, V, Giovannelli, J, Allanore, Y, Riemekasten, G, Airò, P, Vettori, S et al.. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. Arthritis Rheumatol. 2019;71 (9):1553-1570. doi: 10.1002/art.40906. PubMed PMID:30969034 PubMed Central PMC6771590.
  122. Elhai, M, Boubaya, M, Distler, O, Smith, V, Matucci-Cerinic, M, Alegre Sancho, JJ et al.. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Ann Rheum Dis. 2019;78 (7):979-987. doi: 10.1136/annrheumdis-2018-214816. PubMed PMID:30967395 .
  123. Bruni, C, Shirai, Y, Kuwana, M, Matucci-Cerinic, M. Cyclophosphamide: similarities and differences in the treatment of SSc and SLE. Lupus. 2019;28 (5):571-574. doi: 10.1177/0961203319840433. PubMed PMID:30961417 .
  124. Antunes, M, Scirè, CA, Talarico, R, Alexander, T, Avcin, T, Belocchi, C et al.. Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. RMD Open. 2018;4 (Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. PubMed PMID:30886731 PubMed Central PMC6397427.
  125. Meyer, A, Scirè, CA, Talarico, R, Alexander, T, Amoura, Z, Avcin, T et al.. Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]. RMD Open. 2018;4 (Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. PubMed PMID:30886730 PubMed Central PMC6397434.
  126. Wu, W, Jordan, S, Graf, N, de Oliveira Pena, J, Curram, J, Allanore, Y et al.. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Ann Rheum Dis. 2019;78 (5):648-656. doi: 10.1136/annrheumdis-2018-213455. PubMed PMID:30852552 PubMed Central PMC6517861.
  127. Wang, Y, Chen, S, Lin, Z, Lin, J, Xie, X, Lin, Q et al.. Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature review. Clin Rheumatol. 2019;38 (5):1433-1436. doi: 10.1007/s10067-019-04462-z. PubMed PMID:30746580 .
  128. Pauling, JD, Frech, TM, Hughes, M, Gordon, JK, Domsic, RT, Anderson, ME et al.. Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report. J Scleroderma Relat Disord. 2018;3 (3):249-252. doi: 10.1177/2397198318774307. PubMed PMID:30705970 PubMed Central PMC6350902.
  129. Blagojevic, J, Bellando-Randone, S, Abignano, G, Avouac, J, Cometi, L, Czirják, L et al.. Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Res Ther. 2019;21 (1):35. doi: 10.1186/s13075-019-1822-1. PubMed PMID:30678703 PubMed Central PMC6346551.
  130. Butler, EA, Baron, M, Fogo, AB, Frech, T, Ghossein, C, Hachulla, E et al.. Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis Rheumatol. 2019;71 (6):964-971. doi: 10.1002/art.40809. PubMed PMID:30614663 .
  131. Wang, Y, Lin, Q, Lin, J, Du, G, Matucci-Cerinic, M. Infliximab Precipitated Urachal Remnant Infection. J Clin Rheumatol. 2021;27 (6):e219-e221. doi: 10.1097/RHU.0000000000000946. PubMed PMID:30585998 .
  132. Andreoli, L, Gerardi, MC, Fernandes, M, Bortoluzzi, A, Bellando-Randone, S, Brucato, A et al.. Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev. 2019;18 (2):164-176. doi: 10.1016/j.autrev.2018.08.008. PubMed PMID:30572134 .
  133. Gargani, L, Todiere, G, Guiducci, S, Bruni, C, Pingitore, A, De Marchi, D et al.. Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2019;12 (5):927-928. doi: 10.1016/j.jcmg.2018.09.025. PubMed PMID:30553664 .
  134. Matucci-Cerinic, M, Allanore, Y, Kavanaugh, A, Buch, MH, Schulze-Koops, H, Kucharz, EJ et al.. Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study. RMD Open. 2018;4 (2):e000757. doi: 10.1136/rmdopen-2018-000757. PubMed PMID:30487998 PubMed Central PMC6242015.
  135. Bruni, C, Ngcozana, T, Braschi, F, Pucci, T, Piemonte, G, Benelli, L et al.. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. J Rheumatol. 2019;46 (6):603-608. doi: 10.3899/jrheum.171486. PubMed PMID:30442833 .
  136. McMahan, ZH, Frech, T, Berrocal, V, Lim, D, Bruni, C, Matucci-Cerinic, M et al.. Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium. J Rheumatol. 2019;46 (1):78-84. doi: 10.3899/jrheum.180004. PubMed PMID:30442827 .
  137. Smith, V, Scirè, CA, Talarico, R, Airo, P, Alexander, T, Allanore, Y et al.. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018;4 (Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. PubMed PMID:30402270 PubMed Central PMC6203100.
  138. Park, JW, Ahn, GY, Kim, JW, Park, ES, Kang, JH, Chang, SH et al.. Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosis. Int J Rheum Dis. 2019;22 (1):96-102. doi: 10.1111/1756-185X.13433. PubMed PMID:30398033 .
  139. Wang, Y, Chen, S, Lin, Z, Du, G, Lin, J, Lin, Q et al.. Imaging and serum biomarkers in connective tissue disease-associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levels. Ann Rheum Dis. 2019;78 (4):573-575. doi: 10.1136/annrheumdis-2018-214098. PubMed PMID:30352891 .
  140. Bellando-Randone, S, Tartarelli, L, Cavigli, E, Tofani, L, Bruni, C, Lepri, G et al.. 18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis. Ann Rheum Dis. 2019;78 (4):577-578. doi: 10.1136/annrheumdis-2018-213376. PubMed PMID:30337426 .
  141. Manetti, M, Pratesi, S, Romano, E, Rosa, I, Bruni, C, Bellando-Randone, S et al.. Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis. Ann Rheum Dis. 2019;78 (4):575-577. doi: 10.1136/annrheumdis-2018-214240. PubMed PMID:30315003 .
  142. Carreira, PE, Carmona, L, Joven, BE, Loza, E, Andreu, JL, Riemekasten, G et al.. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. ;36 Suppl 113 (4):68-75. . PubMed PMID:30277860 .
  143. Fiori, G, Marzi, T, Bartoli, F, Bruni, C, Ciceroni, C, Palomba, M et al.. The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction. Clin Exp Rheumatol. ;36 Suppl 113 (4):135-141. . PubMed PMID:30277859 .
  144. Bruni, C, Frech, T, Manetti, M, Rossi, FW, Furst, DE, De Paulis, A et al.. Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?. Front Immunol. 2018;9 :2045. doi: 10.3389/fimmu.2018.02045. PubMed PMID:30245695 PubMed Central PMC6137210.
  145. Abignano, G, Blagojevic, J, Bissell, LA, Dumitru, RB, Eng, S, Allanore, Y et al.. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology (Oxford). 2019;58 (2):254-259. doi: 10.1093/rheumatology/key271. PubMed PMID:30239834 .
  146. Gargani, L, Bruni, C, Barskova, T, Hartwig, V, Marinelli, M, Trivella, MG et al.. Near-infrared spectroscopic imaging of the whole hand: A new tool to assess tissue perfusion and peripheral microcirculation in scleroderma. Semin Arthritis Rheum. 2019;48 (5):867-873. doi: 10.1016/j.semarthrit.2018.08.002. PubMed PMID:30205980 .
  147. Di Paola, M, Gatti, D, Viapiana, O, Cianferotti, L, Cavalli, L, Caffarelli, C et al.. Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck. Osteoporos Int. 2019;30 (2):391-402. doi: 10.1007/s00198-018-4686-3. PubMed PMID:30178159 .
  148. Carreira, PE, Carmona, L, Joven, BE, Loza, E, Andréu, JL, Riemekasten, G et al.. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol. 2019;48 (1):42-51. doi: 10.1080/03009742.2018.1459830. PubMed PMID:30039730 .
  149. Romano, E, Manetti, M, Rosa, I, Fioretto, BS, Ibba-Manneschi, L, Matucci-Cerinic, M et al.. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Ann Rheum Dis. 2018;77 (11):1665-1674. doi: 10.1136/annrheumdis-2018-213239. PubMed PMID:30021803 .
  150. Gargani, L, Voilliot, D, D'Alto, M, Agoston, G, Moreo, A, Serra, W et al.. Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists. Heart Fail Clin. 2018;14 (3):271-281. doi: 10.1016/j.hfc.2018.02.004. PubMed PMID:29966626 .
  151. Gragnani, L, Cerretelli, G, Lorini, S, Steidl, C, Giovannelli, A, Monti, M et al.. Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis. Aliment Pharmacol Ther. 2018;48 (4):440-450. doi: 10.1111/apt.14845. PubMed PMID:29952013 .
  152. Cavagna, L, Gonzalez Gay, MA, Allanore, Y, Matucci-Cerinic, M. Interstitial pneumonia with autoimmune features: a new classification still on the move. Eur Respir Rev. 2018;27 (148):. doi: 10.1183/16000617.0047-2018. PubMed PMID:29950308 .
  153. Bartoli, F, Bae, S, Cometi, L, Matucci Cerinic, M, Furst, DE. Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018. Expert Rev Clin Immunol. 2018;14 (7):539-547. doi: 10.1080/1744666X.2018.1487291. PubMed PMID:29925278 .
  154. Jaeger, VK, Valentini, G, Hachulla, E, Cozzi, F, Distler, O, Airó, P et al.. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. Arthritis Rheumatol. 2018;70 (11):1829-1834. doi: 10.1002/art.40557. PubMed PMID:29781588 .
  155. Wang, Y, Zhao, S, Du, G, Ma, S, Lin, Q, Lin, J et al.. Acute fibrinous and organizing pneumonia as initial presentation of primary Sjögren's syndrome: a case report and literature review. Clin Rheumatol. 2018;37 (7):2001-2005. doi: 10.1007/s10067-018-4128-9. PubMed PMID:29717396 .
  156. Ingegnoli, F, Schioppo, T, Allanore, Y, Caporali, R, Colaci, M, Distler, O et al.. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus. Semin Arthritis Rheum. 2019;48 (4):686-693. doi: 10.1016/j.semarthrit.2018.03.019. PubMed PMID:29706243 .
  157. Napolitano, F, Rossi, FW, Pesapane, A, Varricchio, S, Ilardi, G, Mascolo, M et al.. N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor. Front Immunol. 2018;9 :574. doi: 10.3389/fimmu.2018.00574. PubMed PMID:29670612 PubMed Central PMC5893650.
  158. Pauling, JD, Saketkoo, LA, Matucci-Cerinic, M, Ingegnoli, F, Khanna, D. The patient experience of Raynaud's phenomenon in systemic sclerosis. Rheumatology (Oxford). 2019;58 (1):18-26. doi: 10.1093/rheumatology/key026. PubMed PMID:29538754 PubMed Central PMC6293480.
  159. Jalil, B, Hartwig, V, Salvetti, O, Potì, L, Gargani, L, Barskova, T et al.. Assessment of hand superficial oxygenation during ischemia/reperfusion in healthy subjects versus systemic sclerosis patients by 2D near infrared spectroscopic imaging. Comput Methods Programs Biomed. 2018;155 :101-108. doi: 10.1016/j.cmpb.2017.12.006. PubMed PMID:29512489 .
  160. Matucci-Cerinic, C, Nagaraja, V, Prignano, F, Kahaleh, B, Bellando-Randone, S. The role of the dermatologist in Raynaud's phenomenon: a clinical challenge. J Eur Acad Dermatol Venereol. 2018;32 (7):1120-1127. doi: 10.1111/jdv.14914. PubMed PMID:29512213 .
  161. Pauling, JD, Domsic, RT, Saketkoo, LA, Almeida, C, Withey, J, Jay, H et al.. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2018;70 (9):1373-1384. doi: 10.1002/acr.23475. PubMed PMID:29473715 PubMed Central PMC5962378.
  162. Bellando-Randone, S, Bruni, C, Lepri, G, Fiori, G, Bartoli, F, Conforti, ML et al.. The safety of iloprost in systemic sclerosis in a real-life experience. Clin Rheumatol. 2018;37 (5):1249-1255. doi: 10.1007/s10067-018-4043-0. PubMed PMID:29470737 .
  163. Gossec, L, Kirwan, JR, de Wit, M, Balanescu, A, Gaujoux-Viala, C, Guillemin, F et al.. Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients. Clin Rheumatol. 2018;37 (6):1503-1510. doi: 10.1007/s10067-018-3998-1. PubMed PMID:29468340 .
  164. Ndosi, M, Alcacer-Pitarch, B, Allanore, Y, Del Galdo, F, Frerix, M, García-Díaz, S et al.. Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis. 2018;77 (7):1032-1038. doi: 10.1136/annrheumdis-2017-212412. PubMed PMID:29463517 PubMed Central PMC6029637.
  165. Distler, O, Allanore, Y, Denton, CP, Matucci-Cerinic, M, Pope, JE, Hinzmann, B et al.. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018;57 (5):813-817. doi: 10.1093/rheumatology/kex504. PubMed PMID:29415230 PubMed Central PMC5913641.
  166. Rotondo, C, Nivuori, M, Chialà, A, Praino, E, Matucci Cerinic, M, Cutolo, M et al.. Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study. Scand J Rheumatol. 2018;47 (4):311-318. doi: 10.1080/03009742.2017.1397187. PubMed PMID:29409385 .
  167. Adler, S, Huscher, D, Siegert, E, Allanore, Y, Czirják, L, DelGaldo, F et al.. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther. 2018;20 (1):17. doi: 10.1186/s13075-018-1517-z. PubMed PMID:29382380 PubMed Central PMC5791165.
  168. Herrick, AL, Peytrignet, S, Lunt, M, Pan, X, Hesselstrand, R, Mouthon, L et al.. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018;77 (4):563-570. doi: 10.1136/annrheumdis-2017-211912. PubMed PMID:29306872 PubMed Central PMC5890636.
  169. Peytrignet, S, Denton, CP, Lunt, M, Hesselstrand, R, Mouthon, L, Silman, A et al.. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford). 2018;57 (2):370-381. doi: 10.1093/rheumatology/kex410. PubMed PMID:29207002 PubMed Central PMC5850714.
  170. Galli, M, Antinori, S, Atzeni, F, Meroni, L, Riva, A, Scirè, C et al.. Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis. Clin Exp Rheumatol. ;35 (6):1018-1028. . PubMed PMID:29185961 .
  171. Allanore, Y, Distler, O, Matucci-Cerinic, M, Denton, CP. Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis. Arthritis Rheumatol. 2018;70 (2):162-170. doi: 10.1002/art.40377. PubMed PMID:29145709 .
  172. Mecacci, F, Simeone, S, Cirami, CL, Cozzolino, M, Serena, C, Rambaldi, MP et al.. Preeclampsia in pregnancies complicated by systemic lupus erythematosus (SLE) nephritis: prophylactic treatment with multidisciplinary approach are important keys to prevent adverse obstetric outcomes. J Matern Fetal Neonatal Med. 2019;32 (8):1292-1298. doi: 10.1080/14767058.2017.1404570. PubMed PMID:29130759 .
  173. Stagi, S, Lepri, G, Rigante, D, Matucci Cerinic, M, Falcini, F. Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. J Child Adolesc Psychopharmacol. 2018;28 (2):124-129. doi: 10.1089/cap.2016.0159. PubMed PMID:29112476 .
  174. Bellando-Randone, S, Matucci-Cerinic, M. The Measurement of the Endothelial Glycocalyx as a New Biomarker of Endothelial Derangement in Systemic Sclerosis: A Challenge for the Future. J Rheumatol. 2017;44 (11):1572-1574. doi: 10.3899/jrheum.170958. PubMed PMID:29093075 .
  175. Terenzi, R, Manetti, M, Rosa, I, Romano, E, Galluccio, F, Guiducci, S et al.. Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium. Sci Rep. 2017;7 (1):13293. doi: 10.1038/s41598-017-13746-w. PubMed PMID:29038523 PubMed Central PMC5643391.
  176. Galluccio, F, Bellucci, E, Porta, F, Tofani, L, De Paulis, A, Bianchedi, D et al.. The waterpolo shoulder paradigm: results of ultrasound surveillance at poolside. BMJ Open Sport Exerc Med. 2017;3 (1):e000211. doi: 10.1136/bmjsem-2016-000211. PubMed PMID:29021905 PubMed Central PMC5633731.
  177. Galluccio, F, Müller-Ladner, U, Furst, DE, Khanna, D, Matucci-Cerinic, M. Points to consider in renal involvement in systemic sclerosis. Rheumatology (Oxford). 2017;56 (suppl_5):v49-v52. doi: 10.1093/rheumatology/kex201. PubMed PMID:28992172 PubMed Central PMC5850113.
  178. Galluccio, F, Allanore, Y, Czirjak, L, Furst, DE, Khanna, D, Matucci-Cerinic, M et al.. Points to consider for skin ulcers in systemic sclerosis. Rheumatology (Oxford). 2017;56 (suppl_5):v67-v71. doi: 10.1093/rheumatology/kex200. PubMed PMID:28992171 PubMed Central PMC5850787.
  179. Johnson, SR, Soowamber, ML, Fransen, J, Khanna, D, Van Den Hoogen, F, Baron, M et al.. There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol. 2018;47 (1):62-70. doi: 10.1080/03009742.2017.1299793. PubMed PMID:28990485 .
  180. Colaci, M, Lumetti, F, Giuggioli, D, Guiducci, S, Bellando-Randone, S, Fiori, G et al.. Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study. Clin Exp Rheumatol. ;35 Suppl 106 (4):179-183. . PubMed PMID:28980901 .
  181. Bellando-Randone, S, Matucci-Cerinic, M. Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions. Curr Rheumatol Rep. 2017;19 (10):65. doi: 10.1007/s11926-017-0684-2. PubMed PMID:28921059 .
  182. Elhai, M, Meune, C, Boubaya, M, Avouac, J, Hachulla, E, Balbir-Gurman, A et al.. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76 (11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. PubMed PMID:28835464 .
  183. Manetti, M, Pratesi, S, Romano, E, Bellando-Randone, S, Rosa, I, Guiducci, S et al.. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS One. 2017;12 (8):e0183102. doi: 10.1371/journal.pone.0183102. PubMed PMID:28797111 PubMed Central PMC5552290.
  184. Matucci-Cerinic, M, Manetti, M, Bruni, C, Chora, I, Bellando-Randone, S, Lepri, G et al.. The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?. Arthritis Res Ther. 2017;19 (1):162. doi: 10.1186/s13075-017-1370-5. PubMed PMID:28683836 PubMed Central PMC5501068.
  185. Melchiorre, D, Manetti, M, Matucci-Cerinic, M. Pathophysiology of Hemophilic Arthropathy. J Clin Med. 2017;6 (7):. doi: 10.3390/jcm6070063. PubMed PMID:28672826 PubMed Central PMC5532571.
  186. Carreira, PE, Carmona, L, Joven, BE, Loza, E, Andreu, JL, Riemekasten, G et al.. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clin Exp Rheumatol. ;35 Suppl 106 (4):114-121. . PubMed PMID:28664832 .
  187. Caforio, ALP, Adler, Y, Agostini, C, Allanore, Y, Anastasakis, A, Arad, M et al.. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38 (35):2649-2662. doi: 10.1093/eurheartj/ehx321. PubMed PMID:28655210 .
  188. Mavrogeni, SI, Schwitter, J, Gargani, L, Pepe, A, Monti, L, Allanore, Y et al.. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls". Semin Arthritis Rheum. 2017;47 (1):79-85. doi: 10.1016/j.semarthrit.2017.03.020. PubMed PMID:28522072 .
  189. Caporali, R, Idolazzi, L, Bombardieri, S, Ferraccioli, G, Gerli, R, Govoni, M et al.. Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study. Clin Exp Rheumatol. ;35 (6):919-928. . PubMed PMID:28516890 .
  190. Bartalesi, F, Scirè, C, Requena-Méndez, A, Abad, MA, Buonfrate, D, Caporali, R et al.. Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today. Clin Exp Rheumatol. ;35 (5):752-765. . PubMed PMID:28516869 .
  191. Khanna, D, Furst, DE, Clements, PJ, Allanore, Y, Baron, M, Czirjak, L et al.. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. ;2 (1):11-18. doi: 10.5301/jsrd.5000231. PubMed PMID:28516167 PubMed Central PMC5431585.
  192. Chora, I, Romano, E, Manetti, M, Mazzotta, C, Costa, R, Machado, V et al.. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis. J Rheumatol. 2017;44 (8):1190-1197. doi: 10.3899/jrheum.160791. PubMed PMID:28507177 .
  193. Jaeger, VK, Distler, O, Maurer, B, Czirják, L, Lóránd, V, Valentini, G et al.. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57 (3):441-450. doi: 10.1093/rheumatology/kex182. PubMed PMID:28499034 .
  194. Chiarello, F, Spitoni, S, Hollander, E, Matucci Cerinic, M, Pallanti, S. An expert opinion on PANDAS/PANS: highlights and controversies. Int J Psychiatry Clin Pract. 2017;21 (2):91-98. doi: 10.1080/13651501.2017.1285941. PubMed PMID:28498087 .
  195. Beyer, C, Huscher, D, Ramming, A, Bergmann, C, Avouac, J, Guiducci, S et al.. Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis. Ann Rheum Dis. 2018;77 (4):626-628. doi: 10.1136/annrheumdis-2016-210834. PubMed PMID:28495672 .
  196. Rossi, FW, Lobasso, A, Selleri, C, Matucci-Cerinic, M, Rivellese, F, Shoenfeld, Y et al.. Autoimmune Tautology in a Complex Case of Polyautoimmunity: Systemic Sclerosis, Autoimmune Liver Involvement, Antiphospholipid Syndrome and Hashimoto's Thyroiditis. Isr Med Assoc J. 2017;19 (3):193-195. . PubMed PMID:28457101 .
  197. Suliman, YA, Bruni, C, Johnson, SR, Praino, E, Alemam, M, Borazan, N et al.. Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition. J Scleroderma Relat Disord. 2017;2 (2):115-120. doi: 10.5301/jsrd.5000236. PubMed PMID:30569018 PubMed Central PMC6296474.
  198. Bruni, C, Guiducci, S, Bellando-Randone, S, Matucci-Cerinic, M. Avascular bone necrosis: An underestimated complication of systemic sclerosis. Semin Arthritis Rheum. 2017;47 (1):e3-e5. doi: 10.1016/j.semarthrit.2017.03.015. PubMed PMID:28438381 .
  199. Rivellese, F, Nerviani, A, Rossi, FW, Marone, G, Matucci-Cerinic, M, de Paulis, A et al.. Mast cells in rheumatoid arthritis: friends or foes?. Autoimmun Rev. 2017;16 (6):557-563. doi: 10.1016/j.autrev.2017.04.001. PubMed PMID:28411167 .
  200. Terao, C, Kawaguchi, T, Dieude, P, Varga, J, Kuwana, M, Hudson, M et al.. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017;76 (6):1150-1158. doi: 10.1136/annrheumdis-2016-210645. PubMed PMID:28314753 PubMed Central PMC6733404.
Search PubMed